Literature DB >> 17613970

High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.

Susan Y Kim1, Ilene B Anderson, Jo Ellen Dyer, Judith C Barker, Paul D Blanc.   

Abstract

INTRODUCTION: Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity.
METHODS: We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects).
RESULTS: Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7).
CONCLUSION: Targeted prevention activities could focus on selected high-risk behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613970      PMCID: PMC2257866          DOI: 10.1080/00952990701312316

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  18 in total

1.  Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users.

Authors:  I P Albery; J Strang; M Gossop; P Griffiths
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  Psychoactive substance use and the risk of motor vehicle accidents.

Authors:  K L L Movig; M P M Mathijssen; P H A Nagel; T van Egmond; J J de Gier; H G M Leufkens; A C G Egberts
Journal:  Accid Anal Prev       Date:  2004-07

3.  Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.

Authors:  Ilene B Anderson; Susan Y Kim; Jo Ellen Dyer; Cindy B Burkhardt; Jayme C Iknoian; Michael J Walsh; Paul D Blanc
Journal:  Ann Emerg Med       Date:  2005-12-28       Impact factor: 5.721

4.  Designing a gamma hydroxybutyrate (GHB) structured telephone-administered survey instrument.

Authors:  Jo E Dyer; Ilene Anderson; Susan Kim; Paul Blanc; Judith Barker
Journal:  J Med Toxicol       Date:  2007-03

5.  Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.

Authors:  Matthias E Liechti; Isabelle Kunz; Peter Greminger; Rudolf Speich; Hugo Kupferschmidt
Journal:  Drug Alcohol Depend       Date:  2005-09-06       Impact factor: 4.492

6.  Gamma-hydroxybutyrate withdrawal syndrome.

Authors:  J E Dyer; B Roth; B A Hyma
Journal:  Ann Emerg Med       Date:  2001-02       Impact factor: 5.721

7.  Forensic cases involving the use of GHB in The Netherlands.

Authors:  Ingrid J Bosman; Klaas J Lusthof
Journal:  Forensic Sci Int       Date:  2003-04-23       Impact factor: 2.395

8.  Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.

Authors:  Judith C Barker; Shana L Harris; Jo E Dyer
Journal:  J Psychoactive Drugs       Date:  2007-06

9.  GHB use among gay and bisexual men.

Authors:  Perry N Halkitis; Joseph J Palamar
Journal:  Addict Behav       Date:  2006-02-10       Impact factor: 3.913

10.  Rapid screening of fentanyl (China White) powder samples by solid-phase radioimmunoassay.

Authors:  G L Henderson; M R Harkey; A D Jones
Journal:  J Anal Toxicol       Date:  1990 May-Jun       Impact factor: 3.367

View more
  14 in total

1.  Monitoring of altered amino acid metabolic pattern in rat urine following intraperitoneal injection with γ-hydroxybutyric acid.

Authors:  Chan Seo; Myungjin Na; Jiyeun Jang; Meejung Park; Boyeon Choi; Sooyeun Lee; Man-Jeong Paik
Journal:  Metabolomics       Date:  2018-08-19       Impact factor: 4.290

Review 2.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

3.  The Impact of Gamma Hydroxybutyrate (GHB) Legal Restrictions on Patterns of Use: Results from an International Survey.

Authors:  Ib Anderson; Sy Kim-Katz; Je Dyer; Pd Blanc
Journal:  Drugs (Abingdon Engl)       Date:  2010-10

4.  Preference for gamma-hydroxybutyrate (GHB) in current users.

Authors:  John M Roll; Thomas Newton; Joy Chudzynski; Jennifer M Cameron; Sterling McPherson; Timothy Fong; Matt Torrington
Journal:  J Exp Anal Behav       Date:  2012-05       Impact factor: 2.468

5.  Area-level socioeconomic status in relation to outcomes in gamma-hydroxybutyrate intoxication.

Authors:  Ilene B Anderson; Susan Y Kim-Katz; Jo Ellen Dyer; Gillian E Earnest; John P Lamb; Paul D Blanc
Journal:  Clin Toxicol (Phila)       Date:  2009-01       Impact factor: 4.467

Review 6.  Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

Authors:  Lawrence P Carter; Daniel Pardi; Jane Gorsline; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-06-02       Impact factor: 4.492

7.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

8.  Systematic assessment of gamma hydroxybutyrate (GHB) effects during and after acute intoxication.

Authors:  Susan Y Kim; Judith C Barker; Ilene B Anderson; Jo Ellen Dyer; Gillian Earnest; Paul D Blanc
Journal:  Am J Addict       Date:  2008 Jul-Aug

Review 9.  Behavioral analyses of GHB: receptor mechanisms.

Authors:  Lawrence P Carter; Wouter Koek; Charles P France
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

Review 10.  γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.

Authors:  Melanie A Felmlee; Bridget L Morse; Marilyn E Morris
Journal:  AAPS J       Date:  2021-01-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.